Drug

Formoterol clinical trials

Also written Foradil and Oxis.

studies test it: 190
open now: 7
in phase 3: 90
first study started: 2002

Counted the way a researcher would: Formoterol with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses formoterol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the formoterol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States: 16 Feb 2001 · FORADIL · NDA 020831 (FDA, Drugs@FDA)
European Union: 28 Apr 2014 · DuoResp Spiromax · EMEA/H/C/002348 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Formoterol: 22
Formoterol Fumarate: 18
Foradil Aerolizer: 5
arformoterol: 5
Brovana: 5

Brand

Foradil: 6
Oxis: 2

Development codes

SCH 045571: 1
MK-5571: 1

In one entry with another drug

Given together, or one or the other

budesonide/formoterol: 31
SCH 418131: 10
Budesonide/formoterol Turbuhaler: 7
BGF: 6
BGF MDI 320/14.4/9.6 μg: 6
BFF: 6
GFF MDI (PT003): 6
BFF MDI 320/9.6 μg: 5

Studies by the year they started

184 studies that test it; most in 2006 (15)

Studies that test formoterol, by start year
Year	Studies
2002	8
2003	4
2004	12
2005	11
2006	15
2007	8
2008	10
2009	10
2010	9
2011	11
2012	6
2013	9
2014	9
2015	12
2016	13
2017	9
2018	2
2019	3
2020	5
2021	3
2022	2
2023	4
2024	4
2025	4
2026	1

By phase

A phase 1/2 study counts in both.

Early Phase 1: 1
Phase 1: 12
Phase 2: 33
Phase 3: 90
Phase 4: 40
No phase: 14

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Pulmonary Disease, Chronic Obstructive: 82
Asthma: 78
Asthma, Exercise-Induced: 3
Bronchitis, Chronic: 3
Bronchiolitis Obliterans: 2
Smoking: 1
Respiratory Distress Syndrome: 1
Diabetes Mellitus, Type 1: 1
Post-Acute COVID-19 Syndrome: 1
Pneumonia: 1
Hypertrophy: 1
Bronchial Hyperreactivity: 1

Who runs them

Industry 134 · Other 56

AstraZeneca (46) · Chiesi Farmaceutici S.p.A. (19) · Dey (15) · Pearl Therapeutics, Inc. (13) · Organon and Co (10) · Sumitomo Pharma America, Inc. (4) · Eurofarma Laboratorios S.A. (3) · Novartis Pharmaceuticals (3)

Often tested with

Tested in the same studies.

Budesonide (78) · Glycopyrrolate (23) · Beclomethasone (14) · Mometasone Furoate (14) · Fluticasone (13) · Tiotropium (11) · Aclidinium (7) · Aclidinium bromide (6)

Related medicines

As reviewed, each with the page that says it.

One of Bronchodilators source
Arformoterol tartrate is one of its enantiomers, counted on its own page source

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test formoterol.

May 2027A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and HyperinflationPhase 4 · AstraZeneca
Jul 2027Evaluating Immunomodulatory Interventions in Post-Acute Sequelae of SARS-CoV-2 InfEctionNot applicable · Huashan Hospital

Studies

Open first, then newest update. How each study uses formoterol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 190

See all 190 studies that test formoterol →

Given beside what is tested · 22 — formoterol is usual care or a partner of the new treatment

Showing 20 of 22.

As the comparator · 44 — what is tested is compared with formoterol

Showing 20 of 44.

Codes

What other systems call formoterol · ClinicalTrials.gg INT006538

MeSH (NLM) D000068759Formoterol FumarateConfirmed ClinicalTrials.gov, NLM
UNII (FDA) 5ZZ84GCW8BFORMOTEROLConfirmed FDA, NLM, Wikidata
Wikidata Q4789167arformoterolConfirmed FDA, NLM, Wikidata
NCI Thesaurus C65754FormoterolOne source FDA
DrugBank DB01274One source Wikidata

System	Code	Name there	Checked by
MeSH (NLM)	D000068759	Formoterol Fumarate	Confirmed ClinicalTrials.gov, NLM
UNII (FDA)	5ZZ84GCW8B	FORMOTEROL	Confirmed FDA, NLM, Wikidata
Wikidata	Q4789167	arformoterol	Confirmed FDA, NLM, Wikidata
NCI Thesaurus	C65754	Formoterol	One source FDA
DrugBank	DB01274	—	One source Wikidata

Also registered as arformoterol (UNII F91H02EBWT · RxNorm 304962) and formoterol fumarate (UNII W34SHF8J2K · RxNorm 998038).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.